Synlogic to Present at the Jefferies Global Healthcare Conference
CAMBRIDGE, Mass., May 23, 2023 (GLOBE NEWSWIRE) — Synlogic, Inc. (Nasdaq:SYBX), the leading company advancing therapeutics based on synthetic biology, today announced that Aoife Brennan, M.B. Ch.B., President and Chief Executive Officer, will present at the Jefferies Global Healthcare Conference being held in New York, NY, June 7-9, 2023.
Related news for (SYBX)
- Synlogic Announces Publication of Preclinical and Clinical Data for SYNB1353 as a Potential Treatment for Classical Homocystinuria
- Sidoti Events, LLC’s Virtual January Micro-Cap Conference
- Synlogic Provides Corporate Update and Outlook for 2024
- Synlogic Announces Contract with the Air Force Research Lab
- Synlogic Announces Abstract Accepted for Poster Presentation at the International Conference on Microbiome Engineering 2023